Palatin Technologies (PTN) EBITDA Margin (QoQ) (2010 - 2026)
Palatin Technologies (PTN) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Palatin Technologies | 39.40 Mn | 39.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 627,543.00 |
| Dec 31, 2025 | -636,854.00 |
| Dec 31, 2023 | 34,775.00 |
| Sep 30, 2023 | 32,496.00 |
| Jun 30, 2023 | -440.00 |
| Mar 31, 2023 | -6,633.00 |
| Dec 31, 2022 | 46,215.00 |
| Sep 30, 2022 | 150,942.00 |
| Jun 30, 2022 | 110,307.00 |
| Mar 31, 2022 | -99,548.00 |
| Dec 31, 2021 | 190,104.00 |
| Sep 30, 2021 | -1.23 Mn |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | -166,813.00 |
| Dec 31, 2020 | -427,378.00 |
| Dec 31, 2019 | -2.24 Mn |
| Sep 30, 2019 | -508,002.00 |
| Sep 30, 2018 | -7.56 Mn |
| Jun 30, 2018 | 6.53 Mn |
| Mar 31, 2018 | -3.35 Mn |